Editor-in-Chief
Robert A. Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology
Oncology
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology Oncology
Deputy Director, Samuel Oschin Comprehensive
Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California
Medical Advisory Board
Michael B. Atkins, MD
Deputy Chief, Division of Hematology-Oncology
Director, Cancer Clinical Trials Office
Beth Israel Deaconess Medical Center
Leader, Renal Cancer Program,
Dana Farber Harvard Cancer Center
Boston, Massachusetts
Ronald M. Bukowski, MD
Director, Department of Experimental Therapeutics
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Christopher G. Wood, MD
Associate Professor, Departments of
Urology and Cancer Biology
University of Texas M.D. Anderson Cancer Center
Houston, Texas
Robert J. Motzer, MD
Attending Physician, Memorial Sloan-Kettering
Cancer Center
New York City
Professor of Medicine
Weill Medical College of Cornell University
Ithaca, New York
Walter M. Stadler, MD
Fred C. Buffett Professor
Departments of Medicine and Surgery
Sections of Hematology-Oncology and Urology
University of Chicago Medical Center
Chicago, Illinois
Nurse Advisory Board
Nancy Moldawer, RN, MSN
Nursing Director
City of Hope Kidney Cancer Program
City of Hope Comprehensive Cancer Center
Duarte, California
Laura Wood, RN, MSN, OCN
Renal Cancer Research Coordinator
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Patient Advocate
Gretchen E. Vaughan
Chief Executive Officer
Kidney Cancer Association
Publishing Staff
Senthil Samy, PhD.,Executive Editors
Vinu Jyothi, MD, MPH., Assoc. Director, Editorial Services
Stu Chapman,Editorial Consultant
Susan Hirschhaut,Director of Advertising and Strategic Initiatives
Matthew McConnell,Design Director
Editorial Offices
330 East 71st St., Suite 6B
New York, NY 10021
Tel: (516) 356-5006
Copyright 2019 Genitourinary Publishing.
All rights reserved. None of the contents may be reproduced in any form
without the permission of the publisher.
Editorial Advisory Board
Arie Belldegrun, MD
David Geffen School of Medicine at UCLA
Los Angeles, California
Steven Campbell, MD
Cleveland Clinic Foundation
Cleveland, Ohio
Janice P. Dutcher, MD
Our Lady of Mercy Medical Center
Comprehensive Cancer Center
Bronx, New York
Timothy Eisen, MD
Royal Marsden Hospital
London, UK
Paul Elson, PhD
Cleveland Clinic Foundation
Cleveland, Ohio
Bernard Escudier, MD
Institut Gustave-Roussy
Villejuif, France
James H. Finke, PhD
Cleveland Clinic Lerner College of
Medicine of Case Western Reserve University
Cleveland, Ohio
Keith Flaherty, MD
Abramson Cancer Center of the
University of Pennsylvania
Philadelphia, Pennsylvania
Daniel J. George, MD
Duke Clinical Research Institute
Durham, North Carolina
Martin Gore, MD
Royal Marsden Hospital
London, UK
Gary Hudes, MD
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Thomas Hutson, DO, PharmD
Baylor University Medical Center
Dallas, Texas
Eric Jonasch, MD
University of Texas MD Anderson Cancer Center
Houston, Texas
Eugene D. Kwon, MD
Mayo Clinic
Rochester, Minnesota
Bradley C. Leibovich, MD
Mayo Clinic
Rochester, Minnesota
Kim A. Margolin, MD
City of Hope National Medical Center
Duarte, California
David Nanus, MD
New York Presbyterian Hospital-
Weill Cornell Medical Center
New York, New York
Andrew C. Novick, MD
Cleveland Clinic Foundation
Cleveland, Ohio
Leslie Oleksowicz, MD
College of Medicine
University of Cincinnati Medical Center
Cincinnati, Ohio
Allan Pantuck, MD
David Geffen School of Medicine at UCLA
Los Angeles, California
Brian Rini, MD
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, Tennessee
Paul Russo, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Ihor S. Saczuk, MD
Hackensack University Medical Center
Hackensack, New Jersey
Domenic A. Sica, MD
Medical College of Virginia
Richmond, Virginia
Jeffrey A. Sosman, MD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
David Swanson, MD
University of Texas MD Anderson Cancer Center
Houston, Texas
Nicholas J. Vogelzang, MD
Nevada Cancer Institute
Las Vegas, Nevada